Literature DB >> 24042243

Early intervention and the treatment of prodrome in schizophrenia: a review of recent developments.

Mohammadreza Mokhtari1, Rajaprabhakaran Rajarethinam.   

Abstract

OBJECTIVE: Strategies for preventing the development of schizophrenia are in their infancy but are associated with much hope and potential. The relatively long prodrome in schizophrenia allows for indicated prevention as an effective intervention. "High-risk" individuals have subtle symptoms and, without intervention, a third would develop psychosis within 1 year, and many will have poor functional outcomes, even in the absence of psychosis. Research in this area is preliminary but encouraging.
METHODS: A literature search was performed using databases including PubMed, PsychInfo, and Cochrane, as well as a search of individual journals through cross-referencing. The search used the following key words: schizophrenia, psychosis, psychotic disorders, first episode, early, prodrome, prodromal, prevention, ultra high risk, at risk, and intervention.
RESULTS: Strategies for preventing the development of schizophrenia are divided into universal, selective, and indicated levels of prevention. The common preventive methods include treatment with antipsychotic medications and psychotherapy. Early intervention helps at risk individuals with symptom reduction and appears to delay conversion to full blown psychosis. However, the criteria for identifying at risk individuals have low predictive value, which raises concerns about unnecessary and potentially harmful interventions.
CONCLUSION: Although a range of interventions appear to be effective in reducing rates of transition to psychosis, they are inadequately differentiated and require further study. Current data suggest that clinicians take an individualized approach to intervention, considering the risk-benefit ratio on a case-by-case basis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24042243     DOI: 10.1097/01.pra.0000435036.83426.94

Source DB:  PubMed          Journal:  J Psychiatr Pract        ISSN: 1527-4160            Impact factor:   1.325


  4 in total

Review 1.  From the prodromal stage of multiple sclerosis to disease prevention.

Authors:  Ruth Ann Marrie; Mark Allegretta; Lisa F Barcellos; Bruce Bebo; Peter A Calabresi; Jorge Correale; Benjamin Davis; Philip L De Jager; Christiane Gasperi; Carla Greenbaum; Anne Helme; Bernhard Hemmer; Pamela Kanellis; Walter Kostich; Douglas Landsman; Christine Lebrun-Frenay; Naila Makhani; Kassandra L Munger; Darin T Okuda; Daniel Ontaneda; Ronald B Postuma; Jacqueline A Quandt; Sharon Roman; Shiv Saidha; Maria Pia Sormani; Jon Strum; Pamela Valentine; Clare Walton; Kathleen M Zackowski; Yinshan Zhao; Helen Tremlett
Journal:  Nat Rev Neurol       Date:  2022-07-15       Impact factor: 44.711

2.  The Multiple Sclerosis Prodrome: Evidence to Action.

Authors:  Helen Tremlett; Kassandra L Munger; Naila Makhani
Journal:  Front Neurol       Date:  2022-01-31       Impact factor: 4.086

3.  Digital Technology Use Among Individuals with Schizophrenia: Results of an Online Survey.

Authors:  Katrina Gay; John Torous; Adam Joseph; Anand Pandya; Ken Duckworth
Journal:  JMIR Ment Health       Date:  2016-05-04

4.  Claims-based proxies of patient instability among commercially insured adults with schizophrenia.

Authors:  Charles Ruetsch; Hyong Un; Heidi C Waters
Journal:  Clinicoecon Outcomes Res       Date:  2018-05-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.